23,036,271
Vote Records
25,695
Companies
11,771
Funds
3,902
Managers

Home › Companies › EDGEWISE THERAPEUTICS INC. › 2023-2024

EDGEWISE THERAPEUTICS INC. 2023-2024 Proxy Voting Records

At EDGEWISE THERAPEUTICS INC.'s shareholder meeting held June 7, 2024, in the 2023-2024 proxy season, 50 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 801 separate fund positions. On the most widely held item on that ballot — Approve an amendment to our certificate of incorporation to limit the liability of certain… — EDGEWISE THERAPEUTICS INC.'s filing reports the proposal as approved, with 99% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: EDGEWISE THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 11, 2024.

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and EDGEWISE THERAPEUTICS INC.’s Form 8-K, filed June 11, 2024 (Item 5.07 on EDGAR). Page generated November 8, 2026.

  • 5Ballot items
  • 50Asset managers
  • 801Fund votes
  • June 7, 2024Meeting date

Results at a glance

Meeting of June 7, 2024: 5 items on EDGEWISE THERAPEUTICS INC.’s Form 8-K, filed June 11, 2024: 3 elected · 2 approved.

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore EDGEWISE THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by EDGEWISE THERAPEUTICS INC.

These tallies are EDGEWISE THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 11, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

EDGEWISE THERAPEUTICS INC. — official shareholder meeting results, meeting held June 7, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Peter Thompson, M.D. 65,082,540---- 17,277,2178,220,319 79%Elected—
Elect Director: Kevin Koch, Ph.D. 75,368,471---- 6,991,2868,220,319 92%Elected—
Elect Director: Jonathan Fox, M.D., Ph.D. 71,894,919---- 10,464,8388,220,319 87%Elected—
2. Ratification of the Appointment of Independent Registered Public Accounting Firm 90,540,9794,01635,081 ---- 99.9%Approved—
3. Amendment to the Amended and Restated Certificate of Incorporation 81,420,504937,8041,449 --8,220,319 99%Approved—

Source: EDGEWISE THERAPEUTICS INC., Form 8-K, filed with the SEC on June 11, 2024 — read the filing on EDGAR.

How asset managers voted at the EDGEWISE THERAPEUTICS INC. 2023-2024 meeting

Each item below shows how the 50 asset managers that disclosed a EDGEWISE THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Jonathan Fox, M.D., Ph.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

87% Majority: yes · of votes cast

FOR 87%
FOR: 71,894,919WITHHELD: 10,464,838
Details: description as filed, official tally, votes by 50 asset managers

Description as filed by funds: Elect the directors named in the attached Proxy Statement to serve until the 2027 Annual Meeting of Stockholders: Jonathan Fox, M.D., Ph.D.

EDGEWISE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Jonathan Fox, M.D., Ph.D.”): 71,894,919 for, 10,464,838 withheld, per its Form 8-K filed June 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of three Class III Directors Each director nominee was duly elected to serve until the 2027 annual meeting of stockholders and until their successor is duly elected and qualified, subject to earlier resignation or removal.”
Support: 87% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 50 asset managers below reported 9,611,450 for, 7,117,230 withheld, 183,752 abstained.

FORWITHHOLD
FOR: 9,611,450ABSTAIN: 183,752WITHHOLD: 7,117,230
Largest asset managers voting on “Elect the directors named in the attached Proxy Statement to serve until the 2027 Annual Meeting of Stockholde” at EDGEWISE THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity1,299,6420 05,853,236Mixed
Vanguard3,945,3820 06,000For
BlackRock2,459,0740 00For
JANUS INVESTMENT FUND593,3740 00For
American Century00 0507,662Withhold
Charles Schwab499,2940 00For
TIAA287,2610 00For
Dimensional00 0189,060Withhold
Equitable98,2390 051,700Mixed
Jackson National00 149,1590Abstain
QUANTITATIVE MASTER SERIES LLC107,4830 00For
Victory Capital00 097,330Withhold
DRIEHAUS MUTUAL FUNDS00 089,994Withhold
SEI69,3450 00For
Lincoln Financial46,2000 019,796Mixed
ALPS ETF Trust00 065,163Withhold
RBB FUND, INC.00 049,550Withhold
Nushares ETF Trust44,5510 00For
Brinker Capital Destinations Trust2,0490 031,511Mixed
AIG/SunAmerica00 028,418Withhold
Northern Trust25,2170 00For
Bridge Builder Trust23,3640 00For
State Street23,2600 00For
Pacific Life23,1880 00For
John Hancock00 21,1830Abstain

Showing the 25 largest of 50 asset managers. All 50 are in the interactive database (link above).

2. Elect Director: Kevin Koch, Ph.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%
FOR: 75,368,471WITHHELD: 6,991,286
Details: description as filed, official tally, votes by 50 asset managers

Description as filed by funds: Elect the directors named in the attached Proxy Statement to serve until the 2027 Annual Meeting of Stockholders: Kevin Koch, Ph.D.

EDGEWISE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Kevin Koch, Ph.D.”): 75,368,471 for, 6,991,286 withheld, per its Form 8-K filed June 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of three Class III Directors Each director nominee was duly elected to serve until the 2027 annual meeting of stockholders and until their successor is duly elected and qualified, subject to earlier resignation or removal.”
Support: 92% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 50 asset managers below reported 10,862,506 for, 6,040,198 withheld, 9,728 abstained.

FORWITHHOLD
FOR: 10,862,506ABSTAIN: 9,728WITHHOLD: 6,040,198
Largest asset managers voting on “Elect the directors named in the attached Proxy Statement to serve until the 2027 Annual Meeting of Stockholde” at EDGEWISE THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity1,302,9020 05,849,976Mixed
Vanguard3,951,3820 00For
BlackRock2,459,0740 00For
JANUS INVESTMENT FUND593,3740 00For
American Century507,6620 00For
Charles Schwab499,2940 00For
TIAA287,2610 00For
Dimensional00 0189,060Withhold
Equitable149,9390 00For
Jackson National139,4310 9,7280Mixed
QUANTITATIVE MASTER SERIES LLC107,4830 00For
Victory Capital97,3300 00For
DRIEHAUS MUTUAL FUNDS89,9940 00For
SEI69,3450 00For
Lincoln Financial65,9960 00For
ALPS ETF Trust65,1630 00For
RBB FUND, INC.49,5500 00For
Nushares ETF Trust44,5510 00For
Brinker Capital Destinations Trust33,5600 00For
AIG/SunAmerica28,4180 00For
Northern Trust25,2170 00For
Bridge Builder Trust23,3640 00For
State Street23,2600 00For
Pacific Life23,1880 00For
John Hancock21,1830 00For

Showing the 25 largest of 50 asset managers. All 50 are in the interactive database (link above).

3. Elect Director: Peter Thompson, M.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

79% Majority: yes · of votes cast

FOR 79%WITHHELD
FOR: 65,082,540WITHHELD: 17,277,217
Details: description as filed, official tally, votes by 50 asset managers

Description as filed by funds: Elect the directors named in the attached Proxy Statement to serve until the 2027 Annual Meeting of Stockholders: Peter Thompson, M.D.

EDGEWISE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Peter Thompson, M.D.”): 65,082,540 for, 17,277,217 withheld, per its Form 8-K filed June 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of three Class III Directors Each director nominee was duly elected to serve until the 2027 annual meeting of stockholders and until their successor is duly elected and qualified, subject to earlier resignation or removal.”
Support: 79% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 50 asset managers below reported 6,691,907 for, 10,013,179 withheld, 207,346 abstained.

FORWITHHOLD
FOR: 6,691,907ABSTAIN: 207,346WITHHOLD: 10,013,179
Largest asset managers voting on “Elect the directors named in the attached Proxy Statement to serve until the 2027 Annual Meeting of Stockholde” at EDGEWISE THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity1,282,5800 05,870,298Mixed
Vanguard3,945,3820 06,000For
BlackRock00 02,459,074Withhold
JANUS INVESTMENT FUND593,3740 00For
American Century00 0507,662Withhold
Charles Schwab499,2940 00For
TIAA287,2610 00For
Dimensional00 0189,060Withhold
Equitable00 0149,939Withhold
Jackson National00 149,1590Abstain
QUANTITATIVE MASTER SERIES LLC00 0107,483Withhold
Victory Capital00 097,330Withhold
DRIEHAUS MUTUAL FUNDS00 089,994Withhold
SEI00 069,345Withhold
Lincoln Financial00 065,996Withhold
ALPS ETF Trust00 065,163Withhold
RBB FUND, INC.00 049,550Withhold
Nushares ETF Trust44,5510 00For
Brinker Capital Destinations Trust00 033,560Withhold
AIG/SunAmerica00 028,418Withhold
Northern Trust25,2170 00For
Bridge Builder Trust00 23,3640Abstain
State Street00 023,260Withhold
Pacific Life00 023,188Withhold
John Hancock00 21,1830Abstain

Showing the 25 largest of 50 asset managers. All 50 are in the interactive database (link above).

4. Amendment to the Amended and Restated Certificate of Incorporation

Official resultCORPORATE GOVERNANCEReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99% Approved · of votes cast

FOR 99%
FOR: 81,420,504AGAINST: 937,804
Details: description as filed, official tally, votes by 50 asset managers

Description as filed by funds: Approve an amendment to our certificate of incorporation to limit the liability of certain officers as permitted by Delaware law.

EDGEWISE THERAPEUTICS INC.’s own tally for this item (“3. Amendment to the Amended and Restated Certificate of Incorporation”): 81,420,504 for, 937,804 against — passed, per its Form 8-K filed June 11, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3: Amendment to the Amended and Restated Certificate of Incorporation”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 50 asset managers below reported 16,823,078 for, 89,354 against.

FOR
FOR: 16,823,078AGAINST: 89,354
Largest asset managers voting on “Approve an amendment to our certificate of incorporation to limit the liability of certain officers as permitt” at EDGEWISE THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity7,152,8780 00For
Vanguard3,951,3820 00For
BlackRock2,459,0740 00For
JANUS INVESTMENT FUND593,3740 00For
American Century507,6620 00For
Charles Schwab499,2940 00For
TIAA287,2610 00For
Dimensional189,0600 00For
Equitable149,9390 00For
Jackson National149,1590 00For
QUANTITATIVE MASTER SERIES LLC107,4830 00For
Victory Capital97,3300 00For
DRIEHAUS MUTUAL FUNDS89,9940 00For
SEI069,345 00Against
Lincoln Financial65,9960 00For
ALPS ETF Trust65,1630 00For
RBB FUND, INC.49,5500 00For
Nushares ETF Trust44,5510 00For
Brinker Capital Destinations Trust33,5600 00For
AIG/SunAmerica28,4180 00For
Northern Trust25,2170 00For
Bridge Builder Trust23,3640 00For
State Street23,2600 00For
Pacific Life23,1880 00For
John Hancock21,1830 00For

Showing the 25 largest of 50 asset managers. All 50 are in the interactive database (link above).

5. Ratification of the Appointment of Independent Registered Public Accounting Firm

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%
FOR: 90,540,979AGAINST: 4,016
Details: description as filed, official tally, votes by 50 asset managers

Description as filed by funds: Ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.

EDGEWISE THERAPEUTICS INC.’s own tally for this item (“2. Ratification of the Appointment of Independent Registered Public Accounting Firm”): 90,540,979 for, 4,016 against — passed, per its Form 8-K filed June 11, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 50 asset managers below reported 16,912,432 for.

FOR
FOR: 16,912,432
Largest asset managers voting on “Ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year endi” at EDGEWISE THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity7,152,8780 00For
Vanguard3,951,3820 00For
BlackRock2,459,0740 00For
JANUS INVESTMENT FUND593,3740 00For
American Century507,6620 00For
Charles Schwab499,2940 00For
TIAA287,2610 00For
Dimensional189,0600 00For
Equitable149,9390 00For
Jackson National149,1590 00For
QUANTITATIVE MASTER SERIES LLC107,4830 00For
Victory Capital97,3300 00For
DRIEHAUS MUTUAL FUNDS89,9940 00For
SEI69,3450 00For
Lincoln Financial65,9960 00For
ALPS ETF Trust65,1630 00For
RBB FUND, INC.49,5500 00For
Nushares ETF Trust44,5510 00For
Brinker Capital Destinations Trust33,5600 00For
AIG/SunAmerica28,4180 00For
Northern Trust25,2170 00For
Bridge Builder Trust23,3640 00For
State Street23,2600 00For
Pacific Life23,1880 00For
John Hancock21,1830 00For

Showing the 25 largest of 50 asset managers. All 50 are in the interactive database (link above).

Largest EDGEWISE THERAPEUTICS INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 93,398,767 shares outstanding at the time of that meeting.

Fund voting reports: top EDGEWISE THERAPEUTICS INC. shareholders by shares voted on “Approve an amendment to our certificate of incorporation to limit the liability of certain…”, 2023-2024
#Asset manager % of shares outstanding
1Fidelity 7.66%
2Vanguard 4.23%
3BlackRock 2.63%
4JANUS INVESTMENT FUND 0.64%
5American Century 0.54%
6Charles Schwab 0.53%
7TIAA 0.31%
8Dimensional 0.20%
9Equitable 0.16%
10Jackson National 0.16%

Reported EDGEWISE THERAPEUTICS INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

EDGEWISE THERAPEUTICS INC. holdings and ownership disclosed for the 2023-2024 proxy season
Holder % outstanding Disclosure
ORBIMED ADVISORS LLC 16.33% 13D
Perceptive Advisors LLC 6.85% 13G
BlackRock 6.80% 13F
JANUS HENDERSON GROUP PLC 5.66% 13G
Vanguard Group 5.14% 13F
Paradigm BioCapital Advisors LP 5.07% 13G
Citadel Advisors 2.94% 13F
Geode Capital 1.47% 13F
State Street 1.30% 13F
Morgan Stanley 0.93% 13F

Percentages above are of 93,398,767 shares outstanding, as reported by EDGEWISE THERAPEUTICS INC. on its Form 10-Q dated April 30, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from EDGEWISE THERAPEUTICS INC.’s 10-Q dated April 30, 2024. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.

EDGEWISE THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Cite this page

proxyvotesnow.com, “EDGEWISE THERAPEUTICS (EWTX) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/edgewise-therapeutics-inc/2024 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.